Health-related Quality of Life in children and adolescents treated for acute lymphoblastic leukaemia (ALL), compared with healthy peers: a longitudinal study of early survivorship.
Saved in:
| Title: | Health-related Quality of Life in children and adolescents treated for acute lymphoblastic leukaemia (ALL), compared with healthy peers: a longitudinal study of early survivorship. |
|---|---|
| Authors: | Premaratne G; University of Melbourne, Melbourne, VIC, Australia., McCarthy M; University of Melbourne, Melbourne, VIC, Australia. mmccarthy@unimelb.edu.au.; Children's Cancer Centre, The Royal Children's Hospital, Melbourne, VIC, Australia. mmccarthy@unimelb.edu.au.; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia. mmccarthy@unimelb.edu.au., Tennant M; Children's Cancer Centre, The Royal Children's Hospital, Melbourne, VIC, Australia.; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Downie P; Children's Cancer Centre, Monash Children's Hospital, Melbourne, VIC, Australia.; Department of Pediatrics, Monash University, Melbourne, VIC, Australia., Hearps S; University of Melbourne, Melbourne, VIC, Australia.; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia., De Luca C; Children's Cancer Centre, The Royal Children's Hospital, Melbourne, VIC, Australia.; Clinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia. |
| Source: | Journal of cancer survivorship : research and practice [J Cancer Surviv] 2026 Aug; Vol. 20 (4), pp. 1341-1350. Date of Electronic Publication: 2024 Dec 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
